Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Buildings (2016)

Bio-Techne has reported Buildings over the past 7 years, most recently at $158.0 million for Q2 2016.

  • Quarterly results put Buildings at $158.0 million for Q2 2016, up 0.64% from a year ago — trailing twelve months through Jun 2016 was $158.0 million (up 0.64% YoY), and the annual figure for FY2016 was $158.0 million, up 0.64%.
  • Buildings for Q2 2016 was $158.0 million at Bio-Techne, up from $157.0 million in the prior quarter.
  • Over the last five years, Buildings for TECH hit a ceiling of $158.0 million in Q2 2016 and a floor of $122.7 million in Q1 2012.
  • Median Buildings over the past 5 years was $146.3 million (2013), compared with a mean of $142.1 million.
  • Biggest five-year swings in Buildings: grew 16.27% in 2013 and later rose 0.64% in 2016.
  • Bio-Techne's Buildings stood at $133.0 million in 2012, then increased by 10.98% to $147.7 million in 2013, then increased by 4.12% to $153.7 million in 2014, then grew by 2.11% to $157.0 million in 2015, then grew by 0.64% to $158.0 million in 2016.
  • The last three reported values for Buildings were $158.0 million (Q2 2016), $157.0 million (Q2 2015), and $153.7 million (Q3 2014) per Business Quant data.